Thu, Jan 29, 2015, 4:09 AM EST - U.S. Markets open in 5 hrs 21 mins

Recent

% | $
Quotes you view appear here for quick access.

Amarantus Bioscience Holdings, Inc Message Board

  • smittysghost smittysghost Aug 29, 2013 2:05 PM Flag

    Positive LymPro Validation News from Becton Dickinson .50 or Higher

    License agreement takes it above $1.00.

    These targets ignore any value attached to MANF which could be in the billions of dollars.

    It's a gift here.

    All IMHO.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Big pharma partnership to develop MANF could happen at any time.

      The current share price is a gift by any rational measure.

      Follow the company on Twitter: @AmarantusBio

    • From today's press release:

      AD represents approximately 10% of overall healthcare spend in the US, a penetration that is expected to deepen as an aging population and improved medicine leads to increased diagnoses. Healthcare spending in the US ranks higher than that of any other country, spending roughly $2 trillion, or 18% of GDP, on healthcare. In 2012, 15.4 million caregivers provided an estimated 17.5 billion hours of unpaid care, valued at more than $216 billion beyond the actual healthcare expenses. AD represents a large portion of this capital expenditure. It is estimated that the cost of caring for people with AD and other dementia's will rocket northwards from an estimated $203 billion in 2013 to a projected $1.2 trillion per year by 2050, with Medicare covering approximately 70% of costs.

      The Company has estimated that peak sales for LymPro will exceed $500 million. On June 13, 2013 , the Company entered into a Laboratory Services Agreement with Becton Dickinson for the development of LymPro using BD Biosciences Custom Technology Team, and LymPro development remains on track to initiate a pivotal clinical study in early 2014 to support commercial launch of LymPro as a Laboratory-Developed Test ("LDT") under the Clinical Laboratory Improvements Act ("CLIA") in the second half of 2014.

    • I wanna get hiiiiiiigh sooooo hiiiiiigh!!!!

      Sentiment: Strong Buy

 
AMBS
0.078+0.001(+1.83%)Jan 28 3:55 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Nokia Corporation
NYSEWed, Jan 28, 2015 4:01 PM EST
Electronic Arts Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST